Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the breast

Henry M. Kuerer(The University of Texas MD Anderson Cancer Center), W. Fraser Symmans(The University of Texas MD Anderson Cancer Center)

Cancer

August 24, 2010

10.1002/cncr.25399

Cited by 67

Related Papers

Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy

|Journal of Clinical Oncology|2007|1.6k

Total RNA yield and microarray gene expression profiles from fine‐needle aspiration biopsy and core‐needle biopsy samples of breast carcinoma

|Cancer|2003|176